{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,3]],"date-time":"2026-06-03T16:48:29Z","timestamp":1780505309160,"version":"3.54.1"},"reference-count":31,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2024,2,4]]},"DOI":"10.7759\/cureus.53542","type":"journal-article","created":{"date-parts":[[2024,2,4]],"date-time":"2024-02-04T09:58:58Z","timestamp":1707040738000},"source":"Crossref","is-referenced-by-count":1,"title":["Iron Deficiency: A Silent Threat in Patients With Heart Failure With Reduced Ejection Fraction"],"prefix":"10.7759","author":[{"given":"Nitin","family":"Sarate","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rahul","family":"Sonawane","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vinayak","family":"Pai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shifa","family":"Karatela","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alhad","family":"Mulkalwar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1093\/eurheartj\/ehw128","article-title":"2016 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure: the Task Force for the diagnosis and treatment of acute and chronic heart failure of the European Society of Cardiology (ESC)Developed with the special contribution of the Heart Failure Association (HFA) of the ESC","volume":"37","author":"Ponikowski P","year":"2016","unstructured":"Ponikowski P, Voors AA, Anker SD, et al.. 2016 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure: the Task Force for the diagnosis and treatment of acute and chronic heart failure of the European Society of Cardiology (ESC)Developed with the special contribution of the Heart Failure Association (HFA) of the ESC. Eur Heart J. 2016, 37:2129-200. 10.1093\/eurheartj\/ehw128","journal-title":"Eur Heart J"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1136\/hrt.2003.025270","article-title":"Clinical epidemiology of heart failure","volume":"93","author":"Mosterd A","year":"2007","unstructured":"Mosterd A, Hoes AW. Clinical epidemiology of heart failure. Heart. 2007, 93:1137-46. 10.1136\/hrt.2003.025270","journal-title":"Heart"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1002\/ejhf.483","article-title":"Epidemiology of heart failure: the prevalence of heart failure and ventricular dysfunction in older adults over time. A systematic review","volume":"18","author":"van Riet EE","year":"2016","unstructured":"van Riet EE, Hoes AW, Wagenaar KP, Limburg A, Landman MA, Rutten FH. Epidemiology of heart failure: the prevalence of heart failure and ventricular dysfunction in older adults over time. A systematic review. Eur J Heart Fail. 2016, 18:242-52. 10.1002\/ejhf.483","journal-title":"Eur J Heart Fail"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1002\/ajh.24820","article-title":"Iron deficiency across chronic inflammatory conditions: international expert opinion on definition, diagnosis, and management","volume":"92","author":"Cappellini MD","year":"2017","unstructured":"Cappellini MD, Comin-Colet J, de Francisco A, et al.. Iron deficiency across chronic inflammatory conditions: international expert opinion on definition, diagnosis, and management. Am J Hematol. 2017, 92:1068-78. 10.1002\/ajh.24820","journal-title":"Am J Hematol"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejim.2018.04.013","article-title":"Iron deficiency in chronic and acute heart failure: a contemporary review on intertwined conditions","volume":"52","author":"Cunha GJ","year":"2018","unstructured":"Cunha GJ, Rocha BM, Menezes Falc\u00e3o L. Iron deficiency in chronic and acute heart failure: a contemporary review on intertwined conditions. Eur J Intern Med. 2018, 52:1-7. 10.1016\/j.ejim.2018.04.013","journal-title":"Eur J Intern Med"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1002\/ajh.24201","article-title":"How we diagnose and treat iron deficiency anemia","volume":"91","author":"Auerbach M","year":"2016","unstructured":"Auerbach M, Adamson JW. How we diagnose and treat iron deficiency anemia. Am J Hematol. 2016, 91:31-8. 10.1002\/ajh.24201","journal-title":"Am J Hematol"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1007\/s12185-017-2373-3","article-title":"Modern iron replacement therapy: clinical and pathophysiological insights","volume":"107","author":"Girelli D","year":"2018","unstructured":"Girelli D, Ugolini S, Busti F, Marchi G, Castagna A. Modern iron replacement therapy: clinical and pathophysiological insights. Int J Hematol. 2018, 107:16-30. 10.1007\/s12185-017-2373-3","journal-title":"Int J Hematol"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1002\/ajh.22108","article-title":"Improved differential diagnosis of anemia of chronic disease and iron deficiency anemia: a prospective multicenter evaluation of soluble transferrin receptor and the sTfR\/log ferritin index","volume":"86","author":"Skikne BS","year":"2011","unstructured":"Skikne BS, Punnonen K, Caldron PH, et al.. Improved differential diagnosis of anemia of chronic disease and iron deficiency anemia: a prospective multicenter evaluation of soluble transferrin receptor and the sTfR\/log ferritin index. Am J Hematol. 2011, 86:923-7. 10.1002\/ajh.22108","journal-title":"Am J Hematol"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1007\/s00277-019-03777-w","article-title":"Iron deficiency in heart failure, an underdiagnosed and undertreated condition during hospitalization","volume":"98","author":"Mistry R","year":"2019","unstructured":"Mistry R, Hosoya H, Kohut A, Ford P. Iron deficiency in heart failure, an underdiagnosed and undertreated condition during hospitalization. Ann Hematol. 2019, 98:2293-7. 10.1007\/s00277-019-03777-w","journal-title":"Ann Hematol"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1093\/eurheartj\/ehq158","article-title":"Iron deficiency: an ominous sign in patients with systolic chronic heart failure","volume":"31","author":"Jankowska EA","year":"2010","unstructured":"Jankowska EA, Rozentryt P, Witkowska A, et al.. Iron deficiency: an ominous sign in patients with systolic chronic heart failure. Eur Heart J. 2010, 31:1872-80. 10.1093\/eurheartj\/ehq158","journal-title":"Eur Heart J"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1016\/j.hfc.2018.08.003","article-title":"Heart failure with reduced ejection fraction in women: epidemiology, outcomes, and treatment","volume":"15","author":"Mentzer G","year":"2019","unstructured":"Mentzer G, Hsich EM. Heart failure with reduced ejection fraction in women: epidemiology, outcomes, and treatment. Heart Fail Clin. 2019, 15:19-27. 10.1016\/j.hfc.2018.08.003","journal-title":"Heart Fail Clin"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijcard.2018.02.021","article-title":"Iron deficiency without anemia is responsible for decreased left ventricular function and reduced mitochondrial complex I activity in a mouse model","volume":"266","author":"Rineau E","year":"2018","unstructured":"Rineau E, Gaillard T, Gueguen N, Procaccio V, Henrion D, Prunier F, Lasocki S. Iron deficiency without anemia is responsible for decreased left ventricular function and reduced mitochondrial complex I activity in a mouse model. Int J Cardiol. 2018, 266:206-12. 10.1016\/j.ijcard.2018.02.021","journal-title":"Int J Cardiol"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCULATIONAHA.118.038516","article-title":"Effect of iron isomaltoside on skeletal muscle energetics in patients with chronic heart failure and iron deficiency","volume":"139","author":"Charles-Edwards G","year":"2019","unstructured":"Charles-Edwards G, Amaral N, Sleigh A, et al.. Effect of iron isomaltoside on skeletal muscle energetics in patients with chronic heart failure and iron deficiency. Circulation. 2019, 139:2386-98. 10.1161\/CIRCULATIONAHA.118.038516","journal-title":"Circulation"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.1002\/ehf2.12101","article-title":"Left ventricular ejection fraction recovery in patients with heart failure treated with intravenous iron: a pilot study","volume":"3","author":"N\u00fa\u00f1ez J","year":"2016","unstructured":"N\u00fa\u00f1ez J, Monmeneu JV, Mollar A, et al.. Left ventricular ejection fraction recovery in patients with heart failure treated with intravenous iron: a pilot study. ESC Heart Fail. 2016, 3:293-8. 10.1002\/ehf2.12101","journal-title":"ESC Heart Fail"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.3390\/jcm8101569","article-title":"Iron deficiency in acute decompensated heart failure","volume":"8","author":"Beale A","year":"2019","unstructured":"Beale A, Carballo D, Stirnemann J, et al.. Iron deficiency in acute decompensated heart failure. J Clin Med. 2019, 8:1569. 10.3390\/jcm8101569","journal-title":"J Clin Med"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.1093\/eurheartj\/ehs224","article-title":"Iron deficiency and heart failure: diagnostic dilemmas and therapeutic perspectives","volume":"34","author":"Jankowska EA","year":"2013","unstructured":"Jankowska EA, von Haehling S, Anker SD, Macdougall IC, Ponikowski P. Iron deficiency and heart failure: diagnostic dilemmas and therapeutic perspectives. Eur Heart J. 2013, 34:816-29. 10.1093\/eurheartj\/ehs224","journal-title":"Eur Heart J"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.1016\/j.jacc.2007.07.029","article-title":"Intravenous iron reduces NT-pro-brain natriuretic peptide in anemic patients with chronic heart failure and renal insufficiency","volume":"50","author":"Toblli JE","year":"2007","unstructured":"Toblli JE, Lombra\u00f1a A, Duarte P, Di Gennaro F. Intravenous iron reduces NT-pro-brain natriuretic peptide in anemic patients with chronic heart failure and renal insufficiency. J Am Coll Cardiol. 2007, 50:1657-65. 10.1016\/j.jacc.2007.07.029","journal-title":"J Am Coll Cardiol"},{"key":"ref18","doi-asserted-by":"publisher","DOI":"10.1152\/ajpgi.00412.2005","article-title":"Iron imports. IV. Hepcidin and regulation of body iron metabolism","volume":"290","author":"Ganz T","year":"2006","unstructured":"Ganz T, Nemeth E. Iron imports. IV. Hepcidin and regulation of body iron metabolism. Am J Physiol Gastrointest Liver Physiol. 2006, 290:G199-203. 10.1152\/ajpgi.00412.2005","journal-title":"Am J Physiol Gastrointest Liver Physiol"},{"key":"ref19","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCULATIONAHA.105.541078","article-title":"Age- and gender-related ventricular-vascular stiffening: a community-based study","volume":"112","author":"Redfield MM","year":"2005","unstructured":"Redfield MM, Jacobsen SJ, Borlaug BA, Rodeheffer RJ, Kass DA. Age- and gender-related ventricular-vascular stiffening: a community-based study. Circulation. 2005, 112:2254-62. 10.1161\/CIRCULATIONAHA.105.541078","journal-title":"Circulation"},{"key":"ref20","doi-asserted-by":"publisher","DOI":"10.1016\/j.gene.2012.09.060","article-title":"Estrogen regulates iron homeostasis through governing hepatic hepcidin expression via an estrogen response element","volume":"511","author":"Hou Y","year":"2012","unstructured":"Hou Y, Zhang S, Wang L, et al.. Estrogen regulates iron homeostasis through governing hepatic hepcidin expression via an estrogen response element. Gene. 2012, 511:398-403. 10.1016\/j.gene.2012.09.060","journal-title":"Gene"},{"key":"ref21","doi-asserted-by":"publisher","DOI":"10.1002\/hep.26648","article-title":"Testosterone perturbs systemic iron balance through activation of epidermal growth factor receptor signaling in the liver and repression of hepcidin","volume":"59","author":"Latour C","year":"2014","unstructured":"Latour C, Kautz L, Besson-Fournier C, et al.. Testosterone perturbs systemic iron balance through activation of epidermal growth factor receptor signaling in the liver and repression of hepcidin. Hepatology. 2014, 59:683-94. 10.1002\/hep.26648","journal-title":"Hepatology"},{"key":"ref22","doi-asserted-by":"publisher","DOI":"10.1093\/infdis\/jiu020","article-title":"Sex, immunity and influenza","volume":"209 Suppl 3","author":"Gabriel G","year":"2014","unstructured":"Gabriel G, Arck PC. Sex, immunity and influenza. J Infect Dis. 2014, 209 Suppl 3:S93-9. 10.1093\/infdis\/jiu020","journal-title":"J Infect Dis"},{"key":"ref23","doi-asserted-by":"publisher","DOI":"10.1038\/nrcardio.2015.109","article-title":"Iron deficiency and cardiovascular disease","volume":"12","author":"von Haehling S","year":"2015","unstructured":"von Haehling S, Jankowska EA, van Veldhuisen DJ, Ponikowski P, Anker SD. Iron deficiency and cardiovascular disease. Nat Rev Cardiol. 2015, 12:659-69. 10.1038\/nrcardio.2015.109","journal-title":"Nat Rev Cardiol"},{"key":"ref24","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2008-12-195651","article-title":"Regulation of iron homeostasis in anemia of chronic disease and iron deficiency anemia: diagnostic and therapeutic implications","volume":"113","author":"Theurl I","year":"2009","unstructured":"Theurl I, Aigner E, Theurl M, et al.. Regulation of iron homeostasis in anemia of chronic disease and iron deficiency anemia: diagnostic and therapeutic implications. Blood. 2009, 113:5277-86. 10.1182\/blood-2008-12-195651","journal-title":"Blood"},{"key":"ref25","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2014.00152","article-title":"Iron at the interface of immunity and infection","volume":"5","author":"Nairz M","year":"2014","unstructured":"Nairz M, Haschka D, Demetz E, Weiss G. Iron at the interface of immunity and infection. Front Pharmacol. 2014, 5:152. 10.3389\/fphar.2014.00152","journal-title":"Front Pharmacol"},{"key":"ref26","doi-asserted-by":"publisher","DOI":"10.1016\/s0005-2728(99)00088-2","article-title":"Iron-dependent changes in cellular energy metabolism: influence on citric acid cycle and oxidative phosphorylation","volume":"1413","author":"Oexle H","year":"1999","unstructured":"Oexle H, Gnaiger E, Weiss G. Iron-dependent changes in cellular energy metabolism: influence on citric acid cycle and oxidative phosphorylation. Biochim Biophys Acta. 1999, 1413:99-107. 10.1016\/s0005-2728(99)00088-2","journal-title":"Biochim Biophys Acta"},{"key":"ref27","doi-asserted-by":"publisher","DOI":"10.1001\/jamacardio.2019.1739","article-title":"Differences in clinical profile and outcomes of low iron storage vs defective iron utilization in patients with heart failure: results from the DEFINE-HF and BIOSTAT-CHF studies","volume":"4","author":"Grote Beverborg N","year":"2019","unstructured":"Grote Beverborg N, van der Wal HH, Klip IT, et al.. Differences in clinical profile and outcomes of low iron storage vs defective iron utilization in patients with heart failure: results from the DEFINE-HF and BIOSTAT-CHF studies. JAMA Cardiol. 2019, 4:696-701. 10.1001\/jamacardio.2019.1739","journal-title":"JAMA Cardiol"},{"key":"ref28","doi-asserted-by":"publisher","DOI":"10.1016\/j.jacc.2011.06.076","article-title":"Pulmonary pressures and death in heart failure: a community study","volume":"59","author":"Bursi F","year":"2012","unstructured":"Bursi F, McNallan SM, Redfield MM, et al.. Pulmonary pressures and death in heart failure: a community study. J Am Coll Cardiol. 2012, 59:222-31. 10.1016\/j.jacc.2011.06.076","journal-title":"J Am Coll Cardiol"},{"key":"ref29","doi-asserted-by":"publisher","DOI":"10.1080\/00015385.2017.1351239","article-title":"Impact of iron deficiency on exercise capacity and outcome in heart failure with reduced, mid-range and preserved ejection fraction","volume":"73","author":"Martens P","year":"2018","unstructured":"Martens P, Nijst P, Verbrugge FH, Smeets K, Dupont M, Mullens W. Impact of iron deficiency on exercise capacity and outcome in heart failure with reduced, mid-range and preserved ejection fraction. Acta Cardiol. 2018, 73:115-23. 10.1080\/00015385.2017.1351239","journal-title":"Acta Cardiol"},{"key":"ref30","doi-asserted-by":"publisher","DOI":"10.1136\/heartjnl-2014-305669","article-title":"Iron deficiency: an emerging therapeutic target in heart failure","volume":"100","author":"Cohen-Solal A","year":"2014","unstructured":"Cohen-Solal A, Leclercq C, Deray G, et al.. Iron deficiency: an emerging therapeutic target in heart failure. Heart. 2014, 100:1414-20. 10.1136\/heartjnl-2014-305669","journal-title":"Heart"},{"key":"ref31","doi-asserted-by":"publisher","DOI":"10.1093\/eurjhf\/hfq165","article-title":"Iron deficiency and anaemia in heart failure: understanding the FAIR-HF trial","volume":"12","author":"Gonz\u00e1lez-Costello J","year":"2010","unstructured":"Gonz\u00e1lez-Costello J, Com\u00edn-Colet J. Iron deficiency and anaemia in heart failure: understanding the FAIR-HF trial. Eur J Heart Fail. 2010, 12:1159-62. 10.1093\/eurjhf\/hfq165","journal-title":"Eur J Heart Fail"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/225922-iron-deficiency-a-silent-threat-in-patients-with-heart-failure-with-reduced-ejection-fraction","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,2,9]],"date-time":"2024-02-09T19:18:27Z","timestamp":1707506307000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/225922-iron-deficiency-a-silent-threat-in-patients-with-heart-failure-with-reduced-ejection-fraction"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,2,4]]},"references-count":31,"URL":"https:\/\/doi.org\/10.7759\/cureus.53542","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2024,2,4]]}}}